Exercise for chemotherapy nerve damage in colorectal or gynecologic cancer
Part of Brain & nervous system clinical trials.
This study tests whether a structured exercise program can help prevent or reduce nerve damage and related symptoms in people starting chemotherapy for colorectal or gynecologic cancer. If you are about to start oxaliplatin or paclitaxel treatment, this trial may offer a way to manage side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with colorectal or gynecologic cancer.
- You are about to start chemotherapy with oxaliplatin or paclitaxel.
- You are able to carry out daily activities and light work (Karnofsky score 70 or higher).
- You have no other condition that already caused nerve damage (like diabetes or heavy alcohol use).
- You are not already doing a similar structured exercise program on a regular basis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if cannabidiol (CBD) can prevent nerve damage (neuropathy) caused by the chemotherapy drug oxaliplatin. If you have colorectal cancer that has spread or cannot be removed by surgery and you are about to start oxaliplatin, you may be able to join.
This study tests whether a personalized exercise program at home can help prevent nerve damage (peripheral neuropathy) caused by certain chemotherapy drugs. It is for people with breast, gynecological, or colon cancer starting a new chemotherapy treatment.
This trial tests if wearing compression gloves and socks during chemotherapy can prevent nerve damage in hands and feet caused by taxane or oxaliplatin treatment. It may help patients avoid numbness, tingling, or pain.
This study tests whether exercise and mindfulness practices can reduce nerve pain and numbness caused by cancer chemotherapy. If you have this side effect, the program may help improve your symptoms and quality of life.
This trial studies an exercise program (PRESIONA) that may help prevent nerve pain or numbness caused by a common type of breast cancer chemotherapy called taxane-based treatment. It targets people with HER2-positive breast cancer who are about to start neoadjuvant chemotherapy.
This study tests if foot reflexology can help prevent nerve damage caused by a chemotherapy drug called oxaliplatin in people with colorectal cancer. If it works, it could reduce pain, tingling, or numbness in the hands and feet.
Hear when a new Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.